Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

CELG:US

120.3100 USD 1.2200 1.00%

As of 20:10:00 ET on 03/02/2015.

Snapshot for Celgene Corp (CELG)

Open: 122.6200 Day's Range: 120.2000 - 122.7800 Volume: 5,197,903
Previous Close: 121.5300 52wk Range: 66.8500 - 125.4500 1-Yr Rtn: +50.12%

Stock Chart for CELG

No chart data available.
  • CELG:US 120.3600
  • 1D
  • 1M
  • 1Y
121.5300
Interactive CELG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CELG

Current P/E Ratio (ttm) 47.0343
Estimated P/E(12/2015) 24.9502
Relative P/E vs. SPX 2.6751
Earnings Per Share (USD) (ttm) 2.5579
Est. EPS (USD) (12/2015) 4.8220
Est. PEG Ratio 0.9554
Market Cap (M USD) 96,319.06
Shares Outstanding (M) 800.59
30 Day Average Volume 5,189,375
Price/Book (mrq) 14.7548
Price/Sale (ttm) 12.5855
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/24/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CELG

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CELG

Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.

Robert J Hugin "Bob"Chairman/CEOMark J AllesPresident/COO
Perry A KarsenCEO:Celgene Cellular TherpeuticsPeter N KelloggExec VP/CFO
More Company Profile & Key Executives for CELG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil